Cardano (ADA) is approaching a critical support level around $0.51, which could decide the next major direction.
1 extracted signal · 1 resolved · 0 still active
More Crypto OnlineIndependent analyst profile- Source published
- 05 Sept 2025, 22:16 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC

AI-generated source summary
The analysis focuses on ADAUSD's weekly chart. It's observed that the price is constrained below a yellow trend line but above the lower boundary of a price channel. This configuration technically allows for price increases, however, ADA's price has been moving within a certain range since the start of the year. Critical level is the 0.51 USD invalidation point. A trend line is noted, acting as an upper range boundary, but the market struggles to exceed it. Consequently, an immediate upward trajectory is not expected. On the shorter time frame, ADAUSD is fluctuating within a support zone. Should the upward support fail, a price point of $0.715 could be reached. The video suggests that currently ADAUSD is in a bearish trend and needs to break above 0.88 USD level to have any confidence in the bullish trend.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
More Crypto Online
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
